Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years

被引:0
作者
Arzu Soybilgic
Karen B Onel
Tammy Utset
Kenneth Alexander
Linda Wagner-Weiner
机构
[1] University of Illinois,
[2] University of Chicago,undefined
来源
Pediatric Rheumatology | / 11卷
关键词
Human papillomavirus; Lupus; Safety; Immunogenicity; Pediatric; Vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 197 条
[1]  
Markowitz LE(2007)Quadrivalent Human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP) MMWR Recomm Rep 56 1-24
[2]  
Dunne EF(2004)Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000 Perspect Sex Reprod Health 36 6-10
[3]  
Saraiya M(1999)Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American social health association panel Sex Transm Dis 26 S2-S7
[4]  
Lawson HW(2005)Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review Int J STD AIDS 16 528-537
[5]  
Chesson H(2010)Are women with lupus at higher risk of HPV infection? Lupus 19 1485-1491
[6]  
Unger ER(1981)Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy Arthritis Rheum 24 648-650
[7]  
Weinstock H(1994)Systemic lupus erythematosus: predisposition for uterine cervical dysplasia Lupus 3 59-61
[8]  
Berman S(2001)Abnormal cervicovaginal cytology in women with lupus: a retrospective cohort study Gynecol Oncol 82 4-6
[9]  
Cates W(2007)High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients Arthritis Rheum 57 619-625
[10]  
Cates W(2000)Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study Lupus 9 542-544